B-Bridge Technology Transfer
Technology Search

Field of Interests:
Opportunity Type:
Key Words:

Results 18 of 18
Chromosome-Engineered Mouse Model for Autism (prof. Tooru Takumi, Hiroshima University) Chromosome-Engineered Mouse Model for Autism (prof. Tooru Takumi, Hiroshima University)
Development of world-first mouse model for autism using copy number variation technique.
08-10-2010

BRANCHED POLYALKYLENE GLYCOL DERIVATIVE, PHOTOSENSITIVE COMPOSITION, CROSSLINKED MATERIAL, AND SUBSTRATE BRANCHED POLYALKYLENE GLYCOL DERIVATIVE, PHOTOSENSITIVE COMPOSITION, CROSSLINKED MATERIAL, AND SUBSTRATE
3D cell culture plate for ES, IPS Cell
04-05-2010

Novel Monoclonal Antibody for Human HB-EGF Novel Monoclonal Antibody for Human HB-EGF
-New DDS Carrier for Heart Failure and Cancers-
03-29-2010

Novel Cancer Drug Candidate Effective against Hypoxia Novel Cancer Drug Candidate Effective against Hypoxia
newly synthesized fusicoccin derivatives
03-29-2010

Supramolecular protein polymer Supramolecular protein polymer
A protein monomer polymerization with pH control
03-29-2010

A novel protein labeling system in vitro and living cells A novel protein labeling system in vitro and living cells
Inventors have developed PYP (Photoactive Yellow Protein; 14kDa) as the candidate tag.
03-29-2010

Anti-malarial Drug Candidates Utilizing Agricultural Reagents Anti-malarial Drug Candidates Utilizing Agricultural Reagents
The inventors have examined inhibitory effects of plant growth regulators using cultured malaria parasites, and found that gibberellin inhibitors and cytokinins revealed anti-malarial activity.
03-29-2010

Application of IL-11 to the Therapeutic Strategy Application of IL-11 to the Therapeutic Strategy
IL-11 treatment rapidly activated STAT3 and extracellular signal-regulated kinase (ERK) 1/2 in cardiac myocytes. IL-11 mediates cytoprotective signals in cardiomyocytes.
03-18-2010

New Anticancer Drugs of Chiral Dinuclear Platinum(II) Complexes New Anticancer Drugs of Chiral Dinuclear Platinum(II) Complexes
Synthesis of a new type of diastereomeric chiral dinuclear platinum complex anticancer drug that has higher tolerability and lower side effects than the current very effective but toxic anticancer platinum drug, oxaliplatin.
03-18-2010

A Novel Mucosal Vaccine Strategy A Novel Mucosal Vaccine Strategy
Applicable for nasal, intestinal, pulmonary, and oral vaccination
03-18-2010

Anti HCV Drug Target in Host protein: PA28γ Anti HCV Drug Target in Host protein: PA28γ
The inhibitor of PA28g can be the promising new drug candidate of novel approach
03-17-2010

Method For Screening Allergic Disease-Related Molecule And Cell Line To Be Used In The Method Method For Screening Allergic Disease-Related Molecule And Cell Line To Be Used In The Method
Toll of screening allergic disease
01-27-2010

Ciclosporin A-binding protein Ciclosporin A-binding protein
New method for Medical development against Hepatitis C
01-21-2010

A Facile Method To Screen Inhibitors of Protein-Protein Interactions A Facile Method To Screen Inhibitors of Protein-Protein Interactions
The Method of development for medical product on new target.protein-protein interaction
01-18-2010

Use of Diabetes-related protein in Diagnosis or Treatment Use of Diabetes-related protein in Diagnosis or Treatment
Use of Diabetes-related, Liver-derived Secreted Protein in Diagnosis or Treatment of Type-2 Diabetes or Vascular Disorder
09-24-2009

Diagnosis and Treatment of Autism - CD38 Diagnosis and Treatment of Autism - CD38
Diagnosis and Treatment of Autism Using CD38
09-23-2009

Diagnosis and Treatment of Crohn's disease Diagnosis and Treatment of Crohn's disease
Diagnosis and Treatment of Crohn's disease by Ergothioneine
09-23-2009

Technology platform capable of producing novel amorphous solid states of pharmaceutical actives in conjunction with stabilizing excipients Technology platform capable of producing novel amorphous solid states of pharmaceutical actives in conjunction with stabilizing excipients
Our company offers a broad technology platform capable of producing novel amorphous solid states of pharmaceutical actives in conjunction with stabilizing excipients
09-04-2009